Both in vitro cell viability and bioluminescence assays, and in vivo BLI and MRI investigations confirmed that these target specific aptamers effectively blocked the VCAM-1 and IL4Rα signals and suppressed the tumor progression in 4T1-bearing mice. Here, VCAM1 is linked to neoplasm.